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The adequate therapeutic approach to patients with lung cancer 
requires precise evaluation of their condition and reliable prognosis 
of the future development of the disease. Our study aims at assess-
ing some basic prognostic factors in patients with lung cancer. 
A total of 366 patients with lung cancer were registered in the 
data-base of the Clinic of Pulmology and were followed up for a peri-
od of 3 years. Prognostic factors were assessed by univariate ana-
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Statistical significance of the difference between 
survival curves assessed by Cox-Mantel test as. 
* - P < 0.05; ** - p < 0.001; *** - p < 0,0001 
l ys i s (Cox-Mante l 
test) and multivari-
able analysis (Cox's 
proportional hazard 
regress ion model). 
Software program-
mes K M S U R V (2) 
and C O X S U R V (3) 
w e r e u s e d in the 
study. The mean sur-
vival time of the pa-
tients, included in 
the study was of 14,3 
± 0.9 months and 
the m e e n survival 
was of 9,0 months. 
The results of the 
univariate and multi-
variate analises are 
shown on table 1 and 
table 2. Stage of dis-
e a s e , Karnofsky ' s 
performance status 
and pleural effusion 
prove to have inde-
pendent prognostic 
s ignif icance. When 
d i s c u s s i n g the re-
sults of our study we 
120 
must underline the considerable prognostic significance of Karnof-
sky's performance status and pleural effusion. This fact is discussed 
by other authors as well and some of them even are ready to add the 
performance status to the criteria that form the TNM classification of 
lung cancer (1,4). 
Table 2 
Variables Hazard ratio p 
Stage III A 1,319 0,17 
Stage III В 1,478 0,06 
Stage IV 2,435 0,0001 
Performance status 0 - 70 0,247 0,0001 
Pleural effusion 1,541 0,02 
The univariate analysis of prognostic factors in lung cancer pa­
tients has identified stage of disease, pleural effusion, number and 
type of metastases and Karnofsky's performance status to be signi­
ficant parameters, predicting the patients' survival. 
The proportional hazard regression model of Cox has shown that 
stage of disease, performance status and pleural effusion have inde­
pendent prognostic significance. 
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